Florabio

Florabio is a specialized developer of advanced cell culture media, leveraging over 27 years of founder expertise in cellular metabolism. The company's value proposition centers on a proprietary platform for rapid custom media development, promising optimized performance for individual client cell lines within weeks. With a foundation built on the legacy of the best-selling ActiCHO medium, Florabio targets the growing biologics manufacturing sector by aiming to improve protein yield and quality through superior nutrition. It operates as a private, likely early-revenue stage company providing critical upstream bioprocessing components.

Proprietary platform for rapid design and formulation of customized cell culture media, optimizing nutrient composition for specific cell clones to enhance growth, productivity, and protein glycosylation profiles.

Florabio competes in the cell culture media market against dominant multinational corporations like Thermo Fisher Scientific (Gibco), Merck Millipore, Sartorius, and Cytiva. Its differentiation lies in deep customization expertise and rapid development speed, targeting clients for whom off-the-shelf media are suboptimal. It is a niche specialist versus full-line generalists.